News | August 27, 2008

ASTRO Selects Pediatric Oncologist as 2008 Honorary Member

August 28, 2008 - The American Society for Therapeutic Radiology and Oncology (ASTRO) has selected renowned pediatric oncologist Audrey Evans, M.D., as its 2008 honorary member.

Dr. Evans, who will be recognized during the Awards Ceremony held Tuesday, Sept. 23, during ASTRO's 50th Annual Meeting in Boston, has been on the forefront of the treatment and study of childhood cancer for decades. She was one of the co-founders of the original Ronald McDonald House, which opened in Philadelphia in 1974 and expanded into Ronald McDonald House Charities in 1984 and the Ronald McDonald Camp in 1987. She also developed the Evans Staging System for neuroblastoma and instituted and chaired the initial meetings of the Advances in Neuroblastoma Research Conference, which began in 1975 and continue to this day.

Over the course of her career, Dr. Evans has been awarded the Janeway Award from the American Radium Society, the American Society of Pediatric Hematology/Oncology Distinguished Career Award, the American Red Cross Spectrum Award, the Alpha Delta Kappa International Woman of the Year Award and the University of Pennsylvania Osler Award, among many other awards. She also has co-authored approximately 250 papers in peer-reviewed literature.

"Dr. Evans is truly a pioneer in the field of pediatric oncology and in patient care," Louis B. Harrison, M.D., chair of ASTRO's Board of Directors and a radiation oncologist at Beth Israel Medical Center in New York, said. "ASTRO is honored to be able to extend an honorary membership to her in recognition of her admirable career and the contributions she has made to cancer patients and the field of oncology."

Dr. Evans attended medical school at the Royal College of Physicians and Surgeons in Edinburgh, UK, and came to the U.S. in 1953 as a Fulbright Fellow at the Boston Children's Hospital. She became the head of the pediatric hematology-oncology unit at the University of Chicago clinics in 1964 and director of the Children's Cancer Center at the Children's Hospital of Philadelphia in 1968.

From 1969-1989, Dr. Evans served as the chair of the Division of Oncology at the Children's Hospital of Philadelphia and was appointed a professor of pediatrics at the University of Pennsylvania School of Medicine in Philadelphia in 1972.

ASTRO Honorary Membership is the highest honor the Society bestows on distinguished cancer researchers and leaders in disciplines other than radiation oncology, radiation physics or radiobiology.

For more information: www.astro.org

Related Content

This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...